VECTOR MUNE FP-MG (FOWL POX-MYCOPLASMA GALLISEPTICAN LIVE FOWL POX VECTOR)

Dosage

Children: Refer to specific guidelines based on the type of fowl and intended use, as dosing is highly variable and specific to the context.

Adults: Refer to specific guidelines based on the type of fowl and intended use, as dosing is highly variable and specific to the context.

Pregnancy

Not applicable.

Breast-feeding

Not applicable.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Prevention of surgical site infections
• Disinfection of skin and mucous membranes
• Treatment of minor wounds and cuts
• Control of microbial contamination in medical devices

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate concentration and application methods.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate concentration and application methods.

Mechanism of action

Galliseptican acts by disrupting the integrity of microbial cell membranes and inhibiting essential cellular processes, leading to cell death. It may also interfere with metabolic pathways crucial for microbial survival, ultimately resulting in the bactericidal or fungicidal effects observed in clinical use.

Pharmacodynamics

Galliseptican demonstrates concentration-dependent antimicrobial activity, meaning its efficacy increases with higher concentrations. It is effective against both Gram-positive and Gram-negative bacteria as well as various fungi. The spectrum of activity and the speed of action can vary depending on the concentration and the specific microorganism.

Pharmacokinetics

The pharmacokinetics of galliseptican are not well-defined due to the limited data available in literature. Generally, antiseptics are applied topically, leading to localized effects with minimal systemic absorption. If absorbed, the metabolism and excretion pathways are not extensively studied, but they may involve hepatic metabolism and renal excretion.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when administering to breastfeeding mothers. Monitor the infant for any adverse effects.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Gene therapy for genetic disorders
• Cancer treatment
• Vaccination against infectious diseases
• Treatment of certain viral infections

Dosage

Children: Dosage varies based on the specific vector and therapeutic application. Refer to specific guidelines or clinical studies for detailed dosing information.

Adults: Dosage varies widely based on the specific vector and therapeutic application. Refer to specific guidelines or clinical studies for detailed dosing information.

Mechanism of action

Vectors, particularly viral vectors, operate by utilizing the natural ability of viruses to infect host cells. They are engineered to carry therapeutic genes into target cells. Once inside the cell, the therapeutic gene can be expressed, leading to the production of a desired protein that can correct a deficiency or inhibit disease progression.

Pharmacodynamics

The pharmacodynamics of vectors depends on the type and design of the vector used. In gene therapy, the effectiveness of a vector is influenced by its ability to target specific cells, the efficiency of gene delivery, and the subsequent expression of the therapeutic gene. These factors can result in altered biological responses, which may include the restoration of normal function in diseased cells or modulation of immune responses in the case of vaccines.

Pharmacokinetics

The pharmacokinetics of vectors involves their distribution, metabolism, and elimination from the body. After administration, vectors must reach target cells to exert their effects. The half-life of vectors can vary significantly based on their type, such as adenoviral, lentiviral, or plasmid vectors. Factors influencing pharmacokinetics include the route of administration, vector stability, and the host immune response, which can lead to rapid clearance of the vector.

Pregnancy

Safety during pregnancy has not been established; caution is advised.

Breast-feeding

Caution is advised as the effects on a nursing infant are unknown.

Storage

Store at room temperature, away from moisture and heat.